Holdings

Mpm Bioimpact LLC

As of Sep 30, 2026, Mpm Bioimpact LLC reported 34 positions worth US$1.23B. Largest: Cullinan Therapeutics, Inc., Aktis Oncology, Inc. and Travere Therapeutics, Inc. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Cullinan Therapeutics, Inc.9.72MUS$149M−10,260Sep 30, 2026
Aktis Oncology, Inc.4.84MUS$94.2Mno changeSep 30, 2026
Travere Therapeutics, Inc.1.09MUS$64.1M−34,368Sep 30, 2026
Edgewise Therapeutics, Inc.1.58MUS$64M−44,793Sep 30, 2026
Dyne Therapeutics, Inc.3.21MUS$51.7M+1.29MSep 30, 2026
Corcept Therapeutics Incorporated422KUS$48.6M−349KSep 30, 2026
Relay Therapeutics, Inc.2.37MUS$42.8M−46,094Sep 30, 2026
Trevi Therapeutics, Inc.2.98MUS$42.7M−94,671Sep 30, 2026
Iovance Biotherapeutics, Inc.2.84MUS$42MnewSep 30, 2026
Liquidia Corporation1.34MUS$40.6M−43,461Sep 30, 2026